22.01.2015 Views

INNOVATORS Gold Award - New Orleans City Business

INNOVATORS Gold Award - New Orleans City Business

INNOVATORS Gold Award - New Orleans City Business

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MEDICAL<br />

Aquadex FlexFlow<br />

Ochsner Health System<br />

Key innovation: an ultrafiltration process to remove<br />

water and salt from the body at a rate controlled by the<br />

attending physician<br />

Biggest clients: cardiovascular patients<br />

Where they’re based: <strong>New</strong> <strong>Orleans</strong><br />

Top executive: Mark French, vice president of the<br />

Ochsner Heart and Vascular Institute<br />

Year introduced: 2007<br />

PHOTO BY FRANK AYMAMI<br />

PATIENTS WITH CONGESTIVE heart failure often suffer<br />

life-threatening excess fluid retention that doctors formerly<br />

removed with intravenous diuretics. That was until<br />

the invention of the Aquadex FlexFlow Fluid Removal<br />

System in 2002.<br />

The Ochsner Heart and Vascular Institute was the first<br />

to use the system locally and has treated some 20 patients<br />

since employing the device last year. The institute credits<br />

cardiologist Dr. Hector Ventura with leading the push to<br />

offer the procedure here.<br />

“I knew many of the people who were involved in the<br />

(development of the) device,” said Ventura, director of the<br />

institute’s Cardiology Residency Program. “This machine<br />

will help take the fluid away without creating more problems<br />

for the patient.”<br />

Aquadex uses ultrafiltration, a process used in dialysis,<br />

to remove water and salt from the body at a rate controlled<br />

by the attending physician. The device can remove up to a<br />

pound of water and salt per hour without adversely affecting<br />

kidney function, heart rate, blood pressure or the electrolyte<br />

balance, according to Congestive Heart Failure<br />

Solutions, the Minneapolis medical device company that<br />

holds the patent for the Aquadex system.<br />

The system is small and portable, engaged by inserting<br />

catheters into patients’ veins. Aquadex patients achieve a<br />

28 percent greater net fluid loss over standard care, according<br />

to the 2006 results of a medical trial of 200 patients,<br />

and a 63 percent reduction in days rehospitalized for heart<br />

failure over standard care. These results reduce medical<br />

costs to hospitals and improve the quality of life for<br />

patients and their families, CHFS emphasizes.<br />

Susan Reyes, a local CHFS representative, said hospitals<br />

can buy the system for $25,000 per unit and offer treatment<br />

for less than $1,000 per session, accounting for disposal<br />

filters that are $900 each.<br />

While Ochsner was first to use the system in the <strong>New</strong><br />

<strong>Orleans</strong> area, Reyes said the procedure is now available at<br />

Tulane Medical Center and the Louisiana State University<br />

Interim Hospital.<br />

Ventura shared one of his most memorable cases to<br />

date, a lady who was treated with the system for seven<br />

days.<br />

“She lost about 30 pounds of fluid. She was very<br />

grateful.”•<br />

— Diana Chandler<br />

Dr. Hector Ventura, cardiologist and director of Ochsner’s Heart and Vascular Institute, led the push to offer the Aquadex System FlexFlow<br />

to remove water and salt from patients.<br />

<strong>New</strong> <strong>Orleans</strong> <strong>City</strong><strong>Business</strong> 35A

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!